[HTML][HTML] Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
Background Tocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 phase 2 trial
F Perrone, MC Piccirillo, PA Ascierto, C Salvarani… - 2020 - pesquisa.bvsalud.org
BackgroundTocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine,(2020), 18, 1,(405) …
F Perrone, MC Piccirillo, PA Ascierto… - JOURNAL OF …, 2021 - iris.unito.it
Following publication of the original article [1] the authors identified that the collaborators of
the TOCIVID-19 investigators, Italy were only available in the supplementary file. The …
the TOCIVID-19 investigators, Italy were only available in the supplementary file. The …
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
F Perrone, MC Piccirillo, PA Ascierto… - Journal of …, 2021 - go.gale.com
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19
prospective trial. - Document - Gale Academic OneFile Use this link to get back to this page …
prospective trial. - Document - Gale Academic OneFile Use this link to get back to this page …
Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 phase 2 trial
F Perrone, MC Piccirillo, PA Ascierto, C Salvarani… - medRxiv, 2020 - medrxiv.org
Background Tocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6) which might
be important in the pathogenesis of interstitial pneumonia. Objective to evaluate efficacy of …
be important in the pathogenesis of interstitial pneumonia. Objective to evaluate efficacy of …
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
F Perrone, MC Piccirillo, PA Ascierto… - JOURNAL OF …, 2020 - iris.univr.it
Background: Tocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
F Perrone, MC Piccirillo, PA Ascierto… - JOURNAL OF …, 2020 - iris.unimore.it
Background: Tocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
F Perrone, MC Piccirillo, PA Ascierto… - JOURNAL OF …, 2020 - arts.units.it
Background: Tocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
F Perrone, MC Piccirillo, PA Ascierto… - JOURNAL OF …, 2020 - irinsubria.uninsubria.it
BackgroundTocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients …
[引用][C] Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine,(2020), 18, 1 …
F Perrone, M Piccirillo, P Ascierto, C Salvarani… - 2021 - boa.unimib.it
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19
prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) …
prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) …